Pfizer Ltd. Share Price & Stock Analysis

Pfizer Ltd. (NSE: PFIZER, BSE: 500680) is a Mumbai, Maharashtra-based company in the Pharmaceuticals industry. With a market capitalisation of ₹17,811 Cr, it ranks #393 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 63 in Pharmaceuticals. At ₹3,857.00 (as of 16 Nov 2026), the share price is 26.6% below its 52-week high of ₹5,257.00 and 7.5% above its 52-week low of ₹3,589.00. The share price is down 24.2% over one year and down 22.9% over three months.

Key Metrics

Current Price₹3,857.00
Market Cap₹17,811 Cr
NSE SymbolPFIZER
BSE Code500680
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio24.5
Return on Equity17.16%
Return on Assets10.77%
52-Week Range₹3,589.00 – ₹5,257.00
1-Year Price Change-24.2%
3-Month Price Change-22.9%
Beta (1Y)0.26
Dividend Yield1.94%
HeadquartersMumbai, Maharashtra
Websitewww.pfizerltd.co.in

Latest Quarterly Results — Q2 FY27

Revenue₹727 Cr
Net Profit₹313 Cr
Net Margin43.1%
EPS (Basic)₹68.47
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Pfizer Ltd. Quarterly Revenue and Profit Trend

Pfizer Ltd. reported revenue of ₹727 Cr in Q2 FY27, up 13.2% from ₹642 Cr in Q2 FY26 and up 11.3% from ₹653 Cr in Q1 FY27. It posted a net profit of ₹313 Cr for the quarter, against a net profit of ₹189 Cr in Q2 FY26 (up 65.7%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹603 Cr (Q1 FY26) to ₹727 Cr (Q2 FY27). The company was profitable in each of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹727 Cr₹313 Cr43.1%
Q1 FY27₹653 Cr₹204 Cr31.3%
Q4 FY26₹629 Cr₹200 Cr31.8%
Q3 FY26₹645 Cr₹142 Cr22.0%
Q2 FY26₹642 Cr₹189 Cr29.4%
Q1 FY26₹603 Cr₹192 Cr31.8%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 63.92% of Pfizer Ltd.'s shares as of Sept 2026, unchanged from Sept 2025. Delivery averaged 51.1% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Pfizer Ltd.

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.

Products and Services

1. Pharmaceuticals-This segment provides various pharmaceutical products. It offers products in various therapeutic areas, including women healthcare, respiratory, multivitamins, cardiovascular, vaccines, and anti-infective. 2. Animal Health-0 3. Segment Adjustment-This segment focuses on animal health, dairy, and poultry businesses. 4. Services-This segment conducts clinical trials, new product development, and undertakes data management for drug development.

Business Segments

1. Pharmaceuticals-100%

Pfizer Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Astrazeneca Pharma India Ltd.₹16,078 Cr85.922.82%₹729 Cr-34.3%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Pfizer Ltd.?

Pfizer Ltd. is trading at ₹3,857.00, with a market capitalisation of ₹17,811 Cr.

Which sector does Pfizer Ltd. belong to?

Pfizer Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Pfizer Ltd.?

Pfizer Ltd. has a P/E of 24.5 and a return on equity of 17.16%.

What is the stock symbol of Pfizer Ltd.?

Pfizer Ltd. is listed on the NSE under the symbol PFIZER and on the BSE under the scrip code 500680.

How has Pfizer Ltd.'s share price moved over the past year?

Pfizer Ltd.'s share price is down 24.2% over one year and down 22.9% over three months. Its 52-week range is ₹3,589.00 to ₹5,257.00.

What were Pfizer Ltd.'s latest quarterly results?

In Q2 FY27, Pfizer Ltd. reported revenue of ₹727 Cr and net profit of ₹313 Cr, with basic EPS of ₹68.47 (standalone, parsed from the company's exchange filing).

How have Pfizer Ltd.'s revenue and profit changed over the past year?

Pfizer Ltd. reported revenue of ₹727 Cr in Q2 FY27, up 13.2% from ₹642 Cr in Q2 FY26 and up 11.3% from ₹653 Cr in Q1 FY27.

What is the promoter holding in Pfizer Ltd.?

Promoters held 63.92% of Pfizer Ltd.'s shares as of Sept 2026, unchanged from Sept 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.